Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNPH1 | O43598 | 6/20 | 0.46 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.46 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.46 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.46 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | FBP1 | P09467 | 1/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.46 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.46 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.46 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29465207 | 1.00 | DNPH1 (0.46) | DNPH1P2RY1TAS1R3TAS1R1PRKAB2 | |
| SCHEMBL8441747 | 0.91 | P2RX3 (0.53) | P2RY1SRCP2RY2SMN1; SMN2P2RX1 | |
| SCHEMBL16108838 | 0.89 | P2RY1 (0.59) | DNPH1P2RY1TAS1R3TAS1R1PRKAB2 | |
| SCHEMBL3859625 | 0.89 | DNPH1 (0.45) | DNPH1P2RY1TAS1R3TAS1R1PRKAB2 | |
| SCHEMBL16700549 | 0.88 | P2RY1 (0.58) | DNPH1P2RY1TAS1R3TAS1R1PRKAB2 | |
| Phosphoric Acid SCHEMBL635802 | 0.86 | PI4KA (0.40) | ADORA1SMN1; SMN2 | |
| SCHEMBL3218602 | 0.86 | DNPH1 (0.44) | DNPH1P2RY1TAS1R3TAS1R1PRKAB2 | |
| SCHEMBL5801879 | 0.86 | DNPH1 (0.44) | DNPH1P2RY1TAS1R3TAS1R1PRKAB2 | |
| SCHEMBL17515130 | 0.85 | DNPH1 (0.45) | DNPH1P2RY1TAS1R3TAS1R1PRKAB2 | |
| SCHEMBL41364 | 0.82 | PI4KA (0.43) | ADORA1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 619 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8268352-B2 | Modified release composition for highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-18 | — | — | US | claimed |
| US-8263125-B2 | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-11 | — | — | US | claimed |
| CN-100558407-C | Preparation contains the clear aqueous solution dosage form of bile acid | YOO SEO HONG (US) | 2009-11-11 | — | — | CN | claimed |
| EP-1624894-A4 | METHODS AND COMPOSITIONS FOR MATURING DENDRITIC CELLS UTILIZING INOSINE-CONTAINING COMPOUNDS | IRX THERAPEUTICS INC (US) | 2009-08-26 | — | — | EP | claimed |
| CN-101048164-A | Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis | YOO SEO HONG (US) | 2007-10-03 | — | — | CN | claimed |
| EP-1819318-A1 | DRIED FORMS OF AQUEOUS SOLUBILIZED BILE ACID DOSAGE FORMULATION | Yoo, Seo Hong (US) | 2007-08-22 | — | — | EP | claimed |
| EP-1814558-A2 | METHODS AND COMPOSITIONS FOR REDUCING NEURODEGENERATION IN AMYOTROPHIC LATERAL SCLEROSIS | Yoo, Seo Hong (US) | 2007-08-08 | — | — | EP | claimed |
| US-20070082863-A1 | Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds | IRX THERAPEUTICS, INC. | 2007-04-12 | — | — | US | claimed |
| US-7166299-B2 | Preparation of aqueous clear solution dosage forms with bile acids | YOO SEO HONG | 2007-01-23 | — | — | US | claimed |
| US-20060142241-A1 | Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis | YOO SEO H | 2006-06-29 | — | — | US | claimed |
| US-20050158408-A1 | Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof | YOO SEO H (US) | 2005-07-21 | — | — | US | claimed |
| US-20050148538-A1 | Adjuvant formulations for bacterial and virus vaccines and method of making same | IRX THERAPEUTICS, INC. | 2005-07-07 | — | — | US | claimed |
| WO-2005003295-A2 | METHODS AND COMPOSITIONS FOR MATURING DENDRITIC CELLS UTILIZING INOSINE-CONTAINING COMPOUNDS | IRX THERAPEUTICS, INC. (US) | 2005-01-13 | — | — | WO | claimed |
| EP-1465639-A2 | ADJUVANT FORMULATIONS FOR BACTERIAL AND VIRUS VACCINES AND METHOD OF MAKING SAME | Immuno-RX, Inc. (US) | 2004-10-13 | — | — | EP | claimed |
| CN-1450914-A | Preparation of clear aqueous solution dosage form containing bile acid | SEO-HONG YOO (US) | 2003-10-22 | — | — | CN | claimed |
| US-20030186933-A1 | Preparation of aqueous clear solution dosage forms with bile acids | YOO SEO HONG (US) | 2003-10-02 | — | — | US | claimed |
| WO-2003049670-A2 | ADJUVANT FORMULATIONS FOR BACTERIAL AND VIRUS VACCINES AND METHOD OF MAKING SAME | IMMUNO-RX, INC. (US) | 2003-06-19 | — | — | WO | claimed |
| EP-1255566-A2 | PREPARATION OF AQUEOUS CLEAR SOLUTION DOSAGE FORMS WITH BILE ACIDS | Yoo, Seo Hong (US) | 2002-11-13 | — | — | EP | claimed |
| US-20020031558-A1 | Preparation of aqueous clear solution dosage forms with bile acids | YOO SEO HONG (US) | 2002-03-14 | — | — | US | claimed |
| WO-2001056547-A2 | PREPARATION OF AQUEOUS CLEAR SOLUTION DOSAGE FORMS WITH BILE ACIDS | YOO SEO HONG (US) | 2001-08-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030186933-A1 | Preparation of aqueous clear solution dosage forms with bile acids | SLC10A2, ABCB11, SLC10A1 | DNPH1 3446/4885P2RY1 731/4885TAS1R3 596/4885 |
| US-20050148538-A1 | Adjuvant formulations for bacterial and virus vaccines and method of making same | ITPA, IMPA1, STING1 | DNPH1 1087/4885P2RY1 539/4885TAS1R3 4401/4885 |
| US-20070082863-A1 | Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds | INMT, STING1, ITPA | DNPH1 1170/4885P2RY1 456/4885TAS1R3 3353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.